- Case Report
- Open Access
Ductal carcinoma in situ (DCIS) in breast fibroadenoma
Egyptian Journal of Radiology and Nuclear Medicine volume 51, Article number: 73 (2020)
Fibroadenoma is the most common benign tumor; although malignant, changes are rare. Any changes or increase in size should be evaluated thoroughly to exclude any malignant formation.
A 25-year-old female presenting to our department complaining of enlargement of the previously stable mass underwent imaging assessment and biopsy which revealed ductal carcinoma in situ changes developed in a fibroadenoma.
Although malignant changes in a fibroadenoma are rare, biopsy of increasing size fibroadenoma is advised to avoid missing any malignant changes; the incidence is more in the complex fibroadenoma.
Fibroadenoma is the most common benign breast neoplasm seen in young women. Although it is benign, there is a very rare risk to develop malignancy; this risk is more evident in complex fibroadenomas and those with a family history of breast cancer. Most of the cases of cancer within fibroadenoma are diagnosed incidentally during a pathological examination. We diagnosed a case of ductal carcinoma in situ which developed within fibroadenoma that showed a recent increase in size after a long time of stability that warrants biopsy which revealed malignant changes; the patient was seen by breast surgeon that decided to do a lumpectomy.
A 25-year-old female is frequently coming to our department to follow up multiple bilateral breast masses by ultrasound; these masses are stable throughout a period of 4 years and appeared circumscribed, transversely oriented, hypoechoic benign-looking, and diagnosed as multiple fibroadenomas. Since the masses were stable for more than 2 years, the case was coded as BIRADS 2. Recently, the patient presented with a 1-month history of increased size of one of the left breast lesions. Ultrasound was done that revealed an increase in the size of the lesion of patient’s concern. This mass appeared homogenous hypoechoic with few foci of calcification and demonstrated mild irregularity of its margin (Fig. 1). The mass showed increased vascularity in color Doppler study, and it measured 3.3 × 2.5 cm. It is located at the inner aspect of the left breast opposite 9 o’clock. Core biopsy was done using a 14-gauge needle (Fig. 2) revealing ductal carcinoma in situ arising in fibroadenoma of low to intermediate nuclear grade and cribriform solid architecture (Fig. 3), PR and ER are negative. This case is the first case diagnosed as DCIS within fibroadenoma in our hospital. The patient has no family history of breast cancer, no skin changes, pain, or nipple discharge; her grandmother had ovarian carcinoma.
The patient then called back to do mammogram and MRI for the evaluation of other masses and to detect any suspicious microcalcification. The mammogram was very dense (Fig. 4); scattered foci of microcalcification are noted, and the mass could not be identified. In post-contrast breast MRI, the concerned mass exhibited low signal intensity on T2WI (Fig. 5) and demonstrated a rapid enhancement in early post-contrast series (Fig. 6) with washout of the peripheral part of the lesion compatible with the areas of DCIS and progressive enhancement of the central portion that could be a part of fibroadenoma in the delayed series (Fig. 7). Type III dynamic curve is identified in the suspicious area (Fig. 8). The patient was seen by a breast surgeon that asked for a biopsy of the other masses that was done and revealed benign lesions. The decision was made for a lumpectomy.
Fibroadenoma is a benign fibroepithelial tumor common in young women; the overall incidence is about 2.2%; they represent about 68% of breast masses, and 70% presented as a single mass and 10–25% as multiple masses . It is composed of connective and epithelial tissues .
Although there is no risk related with fibroadenoma to breast cancer, very rare malignant changes can develop within the fibroadenoma . Some studies have revealed that malignant transformation is seen more in complex fibroadenoma than simple one whereas another study reported that the risk is highly associated with the percentage of epithelial proliferation within the fibroadenoma rather than the presence of fibroadenoma itself . Because the malignancy is rare in fibroadenoma, conservative management with follow-up is accepted except if the mass has progressed in size .
The incidence of a carcinoma evolving within a fibroadenoma represents 0.002 to 0.0125%, in which only 20% of these were DCIS , other malignancies as lobular carcinoma in situ; invasive ductal and lobular carcinomas are also seen [6, 7]. In our case, the case is considered as simple fibroadenoma with DCIS developed on top.
A recent publication considers a woman with complex fibroadenoma in the presence of a family history of breast cancer as a risk factor that should start mammographic screening at an early age .
The management of fibroadenoma differs according to the age of the patient. Those below 35, if the regression of the mass is noted, should consider further follow-up until the mass regressed and disappear completely. If the mass is stable by the age of 35 after 6–12 months follow-up, then excision is advised. On the other hand, if the mass has increased, immediate surgical excision is performed .
If the age is above 35 with a stable or increased size of fibroadenoma after a follow-up of 6–12 months, excision is advised; however, the complex fibroadenoma should be surgically removed . Our case referred to a breast surgeon that decided surgical removal of the mass.
The imaging findings of carcinoma arising from a fibroadenoma were reported in few studies that demonstrate a non-circumscribe indistinct margins, and clustered microcalcifications within the mass in mammogram should raise the suspicion of malignancy while in ultrasound, a focal increase of color flow signals within the mass on color Doppler study or increase size raise suspicion of malignancy . In our case, the mammogram is markedly dense, and the mass cannot be appreciated. Scattered microcalcification is noted, with no suspicious microcalcification at the anticipated site of the mass. The alarming signs were demonstrated in ultrasound that identifies the enlargement of the mass and the irregular appearance of the margin.
Typically, on MRI, fibroadenoma appears as a round or oval-shaped mass with a smooth margin. Fibroadenoma can exhibit variable enhancement; however, enhancement usually persists until the delayed phase . Few reports described dynamic contrast-enhanced breast MRI (DCE-b MRI) findings of carcinoma within fibroadenoma as a mass showing a pattern of early peak enhancement in the central area and delayed rim enhancement in the periphery, and in histology, DCIS was found in the center of the fibroadenoma . Others described that the area of DCIS within the fibroadenoma showed rapid initial enhancement and washout kinetics on DCE-b MRI, whereas the major part of the mass was consistent with fibroadenoma . In our case, DCE-b MRI demonstrates early rapid and delayed washout enhancement in the majority of the mass and progressive enhancement of its central portion which might represent a remaining part of fibroadenoma.
Although fibroadenoma is a benign lesion, it rarely can harbor a malignant cell; thus, follow-up is advised, and biopsy and/or excision if any progressive changes is seen. Multifocality does not always equal benignity, and each lesion should be assessed separately to identify potential breast cancer and/or high-risk lesions.
Availability of data and materials
The case and the images are available from the Radiology Department, Women’s Imaging Section in National Guard Hospital, Riyadh, Kingdom of Saudi Arabia
- DCE-b MRI:
Dynamic contrast enhancement breast magnetic resonance imaging
Ductal carcinoma in situ
Lee M, Soltanian HT (2015) Breast fibroadenomas in adolescents: current perspectives. Adolesc. Health Med. Ther. 6:159–163 Published 2015 Sep 2
Greenberg R, Skornick Y, Kaplan O (1998) Management of breast fibroadenomas. J. Gen. Intern. Med. 13:640–645
Shaik A, Ruterbusch J, Abdulfatah E, Shrestha R, Daaboul M, Pardeshi V et al (2018) Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease. Breast Cancer Res. 20(1):91
Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS et al (1994) Long-term risk of breast cancer in women with fibroadenoma. N. Engl. J. Med. 331:10–15
Nassar A, Visscher DW, Degnim AC et al (2015) Complex fibroadenoma and breast cancer risk: a Mayo Clinic benign breast disease cohort study. Breast Cancer Res. Treat. 153(2):397–405
Kuijper A, Preisler-Adams SS, Rahusen FD, Gille JJ, van der Wall E, van Diest PJ (2002) Multiple fibroadenomas harboring carcinoma in situ in a woman with a family history of breast/ovarian cancer. J. Clin. Pathol. 55:795–797
Aydin OU, Soylu L, Ercan A, Bilezikçi B, Koçak S (2015) Invasive ductal carcinoma developing from fibroadenoma. J Breast Health 11(4):195–198
Saadallah F, Bouraoui I, Naija L, Sakhri S, Zemni I, Hassouna JB, Dhieb TB, Bouzaiene H, Rahal K (2019) Coexistence of invasive ductal breast carcinoma and fibroadenoma. Pan Afr Med J 33
Wu YT, Chen ST, Chen CJ, Kuo YL, Tseng LM, Chen DR et al (2014) Breast cancer arising within fibroadenoma: collective analysis of case reports in the literature and hints on treatment policy. World J Surg Oncol. 12:335
Gollapalli V, Bibi AK, Shah S, Gilchrist B (2017) DCIS breast arising in a fibroadenoma- case report of a rare condition. Clin Surg. 2:1312
Park EK, Cho KR, Seo BK, Woo OH, Hyeon J, Song SE, Bae JW (2015) Radiologic findings of ductal carcinoma in situ arising within a juvenile fibroadenoma: mammographic, sonographic and dynamic contrast-enhanced breast MRI feature. Iran. J. Radiol. 12(2):e17916
Kato F, Omatsu T, Matsumura W, Takahashi M, Hosoda M, Takahashi H et al (2011) Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma. Magn. Reson. Med. Sci. 10(2):129–132
Shin JH, Choi HY, Lee SN, Kim YJ (2006) Microinvasive ductal carcinoma arising within a fibroadenoma: a case report. Acta Radiol. 47(7):643–645
Ethics approval and consent to participate
Ethics approval of the patient’s consent for publication in the case report is waived in our NGHA organization. We had only a consent form for biopsy. A written approval was obtained from the participant.
Consent for publication
The authors consented for the submission of the manuscript and publication. I got written approvals from the authors to publish. The patient included in this research gave written informed consent to publish the data contained within this study. The authors disclosed no competing interests and no relevant relationships.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
El-Essawy, M., AL Haidary, A. & Khan, A. Ductal carcinoma in situ (DCIS) in breast fibroadenoma. Egypt J Radiol Nucl Med 51, 73 (2020). https://doi.org/10.1186/s43055-020-00191-5
- Breast cancer